Autori: Elstein Deborah
| Naslov | Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease (Article) |
| Autori | van Dussen Laura Zimran An Akkerman EM Aerts JMFG Petakov Milan S Elstein Deborah Rosenbaum H Aviezer David Brill-Almon Einat Chertkoff Raul Maas M Hollak CEM |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2013), vol. 50 br. 3, str. 206-211 |
| Projekat | Protalix Biotherapeutics |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Long-term safety and efficacy data of taliglucerase alfa, a Plant cell-expressed recombinant glucocerebrosidase, in the treatment of naive Gaucher disease patients: 36-Month Results (Meeting Abstract) |
| Autori | Zimran Ari Mehta Atul Giraldo Pilar Rosenbaum Hanna Giona Fiorina Amato Dominick J Petakov Milan S Terreros Munoz Eduardo Eduardo Solorio-Meza Sergio Duran Gloria Elstein Deborah Chertkoff Raul Brill-Almon Einat |
| Info | MOLECULAR GENETICS AND METABOLISM, (2013), vol. 108 br. 2, str. S102-S102 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease (Erratum - errors in Affiliations - vol 118, pg 5767, 2011) (Correction) |
| Autori | Zimran Ari Brill-Almon Einat Chertkoff Raul Petakov Milan S Blanco-Favela Francisco Munoz Eduardo Terreros Solorio Meza Sergio Eduardo Amato Dominick J Duran Gloria Giona Florina Heitner Rene Rosenbaum Hanna Giraldo Pilar Mehta Atul Park Glen Phillips Mici Elstein Deborah Altarescu Gheona Szleifer Mali Hashmueli Sharon Aviezer David |
| Info | BLOOD, (2012), vol. 119 br. 19, str. 4577-4577 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Long Term Safety and Efficacy Data of Taliglucerase Alfa, a Plant Cell Expressed Recombinant Glucocerebrosidase, in Treatment Of Naive Gaucher Disease Patients (Meeting Abstract) |
| Autori | Zimran Ari Heitner Rene Mehta Atul Giraldo Pllar Rosenbaum Hanna Giona Florina Amato Dominick J Petakov Milan S Meillon Garcia Luis Antonio Solorio Meza Sergio Eduardo Duran Gloria Elstein Deborah Brill-Almon Einat |
| Info | MOLECULAR GENETICS AND METABOLISM, (2012), vol. 105 br. 2, str. S68-S68 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Significant, Continuous Improvement in Bone Mineral Density (Bmd) Among Type 1 Gaucher Disease Patients Treated with Velaglucerase Alfa: 69-Month Experience, Including Dose Reduction (Meeting Abstract) |
| Autori | Elstein Deborah Foldes Joseph A Zahrieh David Cohn Gabriel M Djordjevic Maja S Brutaru Costin Zimran An |
| Info | JOURNAL OF INHERITED METABOLIC DISEASE, (2011), vol. 34 br. , Suppl. 3, str. S223-S223 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction (Article) |
| Autori | Elstein Deborah Foldes Joseph A Zahrieh David Cohn Gabriel M Djordjevic Maja S Brutaru Costin Zimran Ari |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2011), vol. 47 br. 1, str. 56-61 |
| Projekat | Shire Human Genetic Therapies ; Protalix Therapeutics ; Genzyme Corporation |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Significant, continuous improvement in Bone Mineral Density (BMD) among type 1 Gaucher disease patients treated with Velaglucerase Alfa: 69-month experience, including dose reduction (Meeting Abstract) |
| Autori | Elstein Deborah Foldes Joseph A Zahrieh David Cohn Gabriel M Djordjevic Maja S Brutaru Costin Zimran An |
| Info | MOLECULAR GENETICS AND METABOLISM, (2011), vol. 102 br. 2, str. S17-S18 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease (Article) |
| Autori | Elstein Deborah Cohn Gabriel M Wang N Djordjevic Maja S Brutaru Costin Zimran An |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2011), vol. 46 br. 1, str. 119-123 |
| Projekat | Shire Human Genetic Therapies ; Genzyme Corporation ; Shire HGT |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
